Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer

Objectives: To evaluate the efficacy of tegafur–uracil (UFT), a prodrug of 5-fluorouracil, plus cisplatin and dexamethasone in patients with docetaxel-refractory prostate cancers. Methods: Twenty-five patients with docetaxel-refractory prostate cancer were administered oral UFT plus intravenous cisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Hiroki, Fukuta, Katsuhiro, Yamada, Kenji, Hirose, Masahito, Naruyama, Hiromichi, Yanai, Yoshimasa, Yamada, Yasuyuki, Watase, Hideki, Kawai, Noriyasu, Tozawa, Keiichi, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Association of Rural Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721295/
https://www.ncbi.nlm.nih.gov/pubmed/29255528
http://dx.doi.org/10.2185/jrm.2938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721295/
https://www.ncbi.nlm.nih.gov/pubmed/29255528
http://dx.doi.org/10.2185/jrm.2938

Ejemplares similares